[1]王想福,陈伟国,叶丙霖,等.从“肝肾同源”理论论治绝经后妇女骨质疏松症的研究进展[J].西部中医药,2019,32(06):155-158.
　WANG Xiangfu,CHEN Weiguo,YE Binglin,et al.Research Progress of Treatment for Osteoporosis of Postmenopausal Women Based on the Theory of ''Same Source of Liver and Kidney ''[J].Western Journal of Traditional Chinese Medicine,2019,32(06):155-158.
点击复制

从“肝肾同源”理论论治绝经后妇女骨质疏松症的研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年06期
页码:
155-158
栏目:
出版日期:
2019-06-15

文章信息/Info

Title:
Research Progress of Treatment for Osteoporosis of Postmenopausal Women Based on the Theory of ''Same Source of Liver and Kidney ''
文章编号:
1004-6852(2019)06-0155-04
作者:
王想福1,陈伟国1,叶丙霖2,石瑞芳1,李淑玲1
1 甘肃省中医院，甘肃 兰州 730050； 2 甘肃省中医药研究院
Author(s):
WANG Xiangfu1, CHEN Weiguo1, YE Binglin2, SHI Ruifang1, LI Shuling1
1 Gansu Provincial Hospital of Traditional Chinese Medicine; Lanzhou 730050, China; 2 Gansu Provincial Academy of Chinese Medicine
关键词:
骨质疏松症; 绝经后; 肝肾同源; 文献研究
Keywords:
osteoporosis;  postmenopausal;  same source of liver and kidney;  literature study
分类号:
R816.8
文献标志码:
A
摘要:
从“肝肾同源”理论入手，对绝经后骨质疏松症病因病机、证候分型、体质分析、治疗等进行综述，介绍绝经后骨质疏松症的最新实验研究、临床研究进展，进一步阐述绝经后妇女骨质疏松症的防治原则，为临床提供治疗依据。
Abstract:
The cause, the pathogenesis, syndrome and patterns, constitution analysis, treatment and others of osteoporosis of postmenopausal women on the foundation of TCM theory ''same source of liver and kidney '' are reviewed to introduce the latest experimental studies and clinical research progress of postmenopausal osteoporosis, to further elucidate the prevention principles of osteoporosis and provide therapeutic reference for clinical work.

相似文献/References:

[1]张德宏,李晶.老年骨质疏松症的病因病机及防治原则探析[J].西部中医药,2013,26(03):90.
　ZHANG Dehong,LI Jing.The Etiology, Pathogenesis and Prevention Principles of Senile Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2013,26(06):90.
[2]张彩凤,程卫东△,王彩霞,等.玫参胶囊治疗围绝经期骨质疏松症60例[J].西部中医药,2012,25(05):16.
　ZHANG Cai-feng,CHENG Wei-dong,WANG Cai-xia,et al.MeiShen Capsule in Treating 60 Cases of Menopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2012,25(06):16.
[3]李晶,宋敏△,罗晓,等.淫羊藿总黄酮对去势大鼠股骨骨组织形态学及生物力学的影响*[J].西部中医药,2014,27(07):13.
　LI Jing,SONG Min,LUO Xiao,et al.Effects of Total Flavonoids of Epimedium on Biodynamics and Bone Morphological Metrology of Ovariectomized Rats[J].Western Journal of Traditional Chinese Medicine,2014,27(06):13.
[4]谢栋,陈大军,马国亮,等.原发性骨质疏松症的骨密度与中医脏腑辨证的相关性研究*[J].西部中医药,2015,28(02):82.
[5]梁敏.绝经后骨质疏松症42例护理体会[J].西部中医药,2015,28(12):129.
[6]李非,李红专,叶丙霖.原发性骨质疏松症的中医药研究现状[J].西部中医药,2016,29(03):136.
　LI Fei,LI Hongzhuan,YE Binlin.Research Status of Primary Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2016,29(06):136.
[7]薄云,夏冰杰,赵丽艳,等.疏肝滋肾汤治疗绝经后女性骨关节炎的临床观察[J].西部中医药,2016,29(07):93.
　BO Yun,XIA Bingjie,ZHAO Liyan,et al.Clinical Observation on ShuGan ZiShen Tang in Osteoarthritis of the Female Patients after the Menopause[J].Western Journal of Traditional Chinese Medicine,2016,29(06):93.
[8]董林,雷宁波,邢涛,等.损伤胶囊对绝经后骨质疏松症患者疼痛、骨密度及骨代谢生化指标的影响[J].西部中医药,2017,30(11):8.
　DONG Lin,LEI Ningbo,XING Tao,et al.The Effects of Damage Capsules on the Pain, Bone Mineral Density and Biochemical Markers of Bone Metabolism of Postmenopausal Osteoporosis Patients[J].Western Journal of Traditional Chinese Medicine,2017,30(06):8.
[9]马风英.仙灵骨葆胶囊联合甲氨蝶呤治疗类风湿性关节炎继发骨质疏松症37例[J].西部中医药,2018,31(02):98.
　MA Fengying.XianLing GuBao Capsules Combined with Methotrexate in Treating 37 Rheumatiod Arthritis Patients with Secondary Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2018,31(06):98.
[10]叶丙霖,李盛华,王想福,等.补肾活血类中药治疗绝经期骨质疏松症的研究进展[J].西部中医药,2018,31(03):136.
　YE Binglin,LI Shenghua,WANG Xiangfu,et al.Study on Kidney-tonifying Blood-activating Herb in Treating Menopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2018,31(06):136.
[11]张长彪,彭冉东,赵军,等.益肾地黄汤联合利塞膦酸钠治疗肾阳虚型绝经后骨质疏松症45例[J].西部中医药,2017,30(04):1.
　ZHANG Changbiao,PENG Randong,ZHAO Jun,et al.YiShen Dihuang Tang Combined with Risedronate Sodium in the Treatment for 45 Cases of Postmenopausal Osteoporosis of Kidney Yang Deficiency Type[J].Western Journal of Traditional Chinese Medicine,2017,30(06):1.
[12]赵军,邓强,彭冉东,等.综合干预方案调治绝经后骨质疏松症患者血瘀质的临床研究[J].西部中医药,2019,32(07):9.
　ZHAO Jun,DENG Qiang,PENG Randong,et al.Clinical Study on Treating Postmenopausal Osteoporosis of Blood Stagnation Constitution with Comprehensive Intervention Regimen[J].Western Journal of Traditional Chinese Medicine,2019,32(06):9.
[13]熊巍,王贵梅.抗骨质疏松胶囊对绝经后骨质疏松症患者骨密度及骨代谢生化指标的影响[J].西部中医药,2022,35(03):104.[doi:10.12174/j.issn.2096-9600.2022.03.23]
　XIONG Wei,WANG Guimei.Influence of Anti-osteoporosis Capsules on Bone Mineral Density and Bone Metabolism Biochemical Markers in Patients with Postmenopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2022,35(06):104.[doi:10.12174/j.issn.2096-9600.2022.03.23]
[14]赵军,师建平.蒙药蓝刺头对去卵巢骨质疏松大鼠TGF-β1、UI、BMD的作用[J].西部中医药,2022,35(07):16.[doi:10.12174/j.issn.2096-9600.2022.07.04]
　ZHAO Jun,SHI Jianping.Influence of Mongolian Medicine Lancitou on TGF-β1, UI and BMD of Ovariectomized Rats with Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2022,35(06):16.[doi:10.12174/j.issn.2096-9600.2022.07.04]
[15]郭晛,任艳玲.中医药基于骨髓脂肪组织能量代谢防治绝经后骨质疏松症机制探讨[J].西部中医药,2023,36(09):51.[doi:10.12174/j.issn.2096-9600.2023.09.11]
　GUO Xian,REN Yanling.Study on the Mechanism of TCM Intervention on Energy Metabolism of Bone Marrow Adipose Tissue in the Prevention and Treatment of Postmenopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2023,36(06):51.[doi:10.12174/j.issn.2096-9600.2023.09.11]

备注/Memo

备注/Memo:
收稿日期：2018-11-01*基金项目：甘肃省中医药管理局科研课题(编号GZK-2016-59);甘肃省自然科学基金项目（编号18JR3RA067）。作者简介：王想福(1969—)，男，主任医师，硕士研究生导师。研究方向：骨科疾病的中医药防治。
更新日期/Last Update: 2019-06-15